Krankenhaus Saarlouis vom DRK
About Krankenhaus Saarlouis vom DRK
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
North Eastern German Society of Gynaecological Oncology
1
Pfizer
1
Clinical Trials at Krankenhaus Saarlouis vom DRK
During the past decade, Krankenhaus Saarlouis vom DRK conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
2017-11-27
2024-03-01
Recruiting
204
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
2020-10-13
2028-04-03
Recruiting
1,900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Saarlouis vom DRK"
#1 collaborator was "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Krankenhaus Saarlouis vom DRK
According to Clinical.Site data, the most researched conditions in "Krankenhaus Saarlouis vom DRK" are
"Breast Neoplasms" (1 trials), "Ovarian Cancer" (1 trials), "Quality of Life" (1 trials) and "Recurrent Ovarian Carcinoma" (1 trials). Many other conditions were trialed in "Krankenhaus Saarlouis vom DRK" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Saarlouis vom DRK
Most popular intervention types in "Krankenhaus Saarlouis vom DRK" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Palbociclib + endocrine therapy" (1 trials) and "Trabectidin (Yondelis)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Saarlouis vom DRK
The vast majority of trials in "Krankenhaus Saarlouis vom DRK" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Krankenhaus Saarlouis vom DRK
Currently, there are NaN active trials in "Krankenhaus Saarlouis vom DRK".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Krankenhaus Saarlouis vom DRK,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Saarlouis vom DRK, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".